My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
most popular
Latest
Listed Series
Buy Hold Sell
Series
Buy Hold Sell
Expert Insights
Fund in Focus
Listed Series
Meet The Investor
Signal or Noise
Success and More Interesting Stuff
The Rules of Investing
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Contributors
Find Funds
About Livewire
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Contact us
Sign out
Sign In
Join Free
Latest
Listed Series
Buy Hold Sell
Series
Buy Hold Sell
Expert Insights
Fund in Focus
Listed Series
Meet The Investor
Signal or Noise
Success and More Interesting Stuff
The Rules of Investing
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Find funds
maxigesic
Latest news and analysis on maxigesic
Equities
AFT’s maiden dividend suggests a rosy future
This month saw AFT Pharmaceutical (AFT) hold its annual shareholders' meeting, and it proved to be a significant milestone for the business as it announced its...
Stephen Bennie
Castle Point Funds
most
popular
Education
An investment that will pay dividends for decades, if not
centuries
Livewire Exclusive,
Livewire Markets
Funds
Buy Hold Sell: 5 of Livewire readers' top ETFs for
2023
Buy Hold Sell,
Livewire Markets
Macro
UBS buys Credit Suisse in CHF3 billion deal, bonds fully protected as AT1s are zeroed (Updated)
Christopher Joye,
Coolabah Capital
Equities
Morgan Stanley says it's time to focus on high-quality names. Here are its 10 top picks in the tech space
Kerry Sun,
Livewire Markets
view all
Sponsored
trending
on livewire
Get the best of Livewire by signing up to our popular daily newsletter
subscribe
